Scrutinio Domenico, Guida Pietro, Dalla Vecchia Laura Adelaide, Corrà Ugo, Passantino Andrea
Istituti Clinici Scientifici Maugeri SpA SB, IRCCS, Institute of Bari, 70100 Bari, Italy.
Istituti Clinici Scientifici Maugeri SpA SB, IRCCS, Institute of Milan, 20138 Milan, Italy.
J Pers Med. 2022 Nov 30;12(12):1980. doi: 10.3390/jpm12121980.
Background: the role that sex plays in impacting cardiac rehabilitation (CR) outcomes remains an important gap in knowledge. Methods: we assessed sex differences in clinical and functional outcomes in 2345 older patients with heart failure (HF) admitted to inpatient CR. Three outcomes were considered: (1) the composite outcome of death during the index admission to CR or transfer to acute care; (2) three-year mortality; (3) change in six-minute walking distance (6MWD) from admission to discharge. Sex differences in outcomes were assessed using multivariable Cox or logistic regression models. Results: the hazard ratios of the composite outcome and of three-year mortality for females vs. males were 0.71 (95%CI:0.50−1.00; p = 0.049) and 0.68 (95%CI:0.59−0.79; p < 0.001), respectively. The standardized mean difference in 6MWD increase from admission to discharge between males and females was 0.10. The odds ratio of achieving an increase in 6MWD at discharge to values higher than the optimal sex-specific thresholds for predicting mortality for females vs. males was 2.21 (95%CI:1.53−3.20; p < 0.001). Conclusion: our findings suggest that older females with HF undergoing CR have better prognosis and garner similar improvement in 6MWD compared with their male counterparts. Nonetheless, females were more likely to achieve levels of functional capacity predictive of improved survival.
性别在影响心脏康复(CR)结局方面所起的作用仍是一个重要的知识空白。方法:我们评估了2345名因心力衰竭(HF)住院接受CR治疗的老年患者在临床和功能结局方面的性别差异。考虑了三个结局:(1)CR索引住院期间死亡或转至急性护理的复合结局;(2)三年死亡率;(3)从入院到出院六分钟步行距离(6MWD)的变化。使用多变量Cox或逻辑回归模型评估结局的性别差异。结果:女性与男性相比,复合结局和三年死亡率的风险比分别为0.71(95%CI:0.50−1.00;p = 0.049)和0.68(95%CI:0.59−0.79;p < 0.001)。男性和女性从入院到出院6MWD增加的标准化平均差异为0.10。出院时6MWD增加到高于预测女性与男性死亡率的最佳性别特异性阈值的比值比为2.21(95%CI:1.53−3.20;p < 0.001)。结论:我们的研究结果表明,接受CR治疗的老年HF女性患者与男性相比预后更好,并且在6MWD方面获得了类似的改善。尽管如此,女性更有可能达到预测生存改善的功能能力水平。